Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Essential Pharma, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
Norgalax.
| Pharmaceutical Form |
|---|
|
Rectal gel. |
Norgalax contains the active ingredient Docusate Sodium 0.12 gin each 10g micro-enema.
| Active Ingredient | Description | |
|---|---|---|
| Docusate |
Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity. |
| List of Excipients |
|---|
|
Glycerol |
A polyethylene tube with fixed applicator and a cap closure, containing 10g of gel in pack sizes of 6 and 100 tubes.
Essential Pharma, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
PL 41871/0007
18/01/2005
| Drug | Countries | |
|---|---|---|
| NORGALAX | France, Netherlands, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
